Vanguard Capital Management LLC has announced an update regarding its stake in Globus Medical Inc, now holding 4.43% of the company. This change was detailed in a recent filing, which highlights the firm's growing interest in the surgical and medical instruments sector.

Vanguard Capital Management, based in Malvern, Pennsylvania, is known for its investment strategies that focus on managing substantial assets. The company is not publicly traded and operates under the Central Index Key (CIK) number 0002100119. The recent filing is part of a series of updates submitted on October 30, 2026.

What the Filing Says

The filing, categorized as a Schedule 13G/A, indicates that Vanguard Capital Management beneficially owns 5,960,866 shares of Globus Medical Inc. This includes 885,307 shares with sole voting power. The document states, "This Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates..."

Impact

This update may affect various stakeholders, including investors and competitors in the surgical and medical instruments sector. The filing suggests that Vanguard's investment strategies could influence market dynamics as they continue to manage significant assets in this industry.

What's Next

The filing does not say what happens next.

Details of Ownership

Vanguard Capital Management's filing reveals that the firm holds a total of 5,960,866 shares of Globus Medical Inc, representing 4.43% of the company's common stock. The filing specifies that Vanguard has sole voting power over 885,307 shares, while retaining sole dispositive power over the entire amount of shares owned. Notably, Vanguard does not share voting or dispositive power with any other entities.

Affiliates Involved

The filing also mentions that Vanguard Capital Management LLC exercises dispositive power over securities held by various affiliates, including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd. This indicates a broader network of investment management capabilities within the Vanguard organization that may influence their strategies and decisions regarding their stake in Globus Medical Inc.

Regulatory Compliance

In accordance with SEC Release No. 34-39538, Vanguard's filing clarifies that the securities reported are held in the ordinary course of business and are not intended to influence the control of Globus Medical Inc. This compliance is crucial for maintaining regulatory standards and reflects Vanguard's commitment to ethical investment practices.

Filing Context

The Schedule 13G/A was filed on October 30, 2026, and is an amendment to a previous filing. This indicates that Vanguard is actively monitoring its investment in Globus Medical and making necessary updates to reflect changes in ownership or strategy. The filing also does not provide information on any future plans or intentions regarding the investment in Globus Medical Inc.